Welcome to our dedicated page for Alphatec Holdings news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Holdings stock.
Alphatec Holdings, Inc. (ATEC) is a leading medical technology company specializing in innovative spine surgery solutions. Our primary focus is the design, development, launch, and delivery of spinal fusion products aimed at improving patient outcomes. By collaborating with spine surgeons, we create and develop products and systems that address the entire spinal fusion procedure, enhancing efficiency and effectiveness.
At Alphatec Spine, we are committed to driving growth through constant innovation. Our product portfolio includes advanced technologies such as Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion. Each of these solutions is designed to simplify surgical procedures for surgeons, ultimately leading to superior patient outcomes.
We pride ourselves on our relentless pursuit of superior outcomes. By continuously developing technologies that positively impact patient care, we strive to be at the forefront of the medical technology industry. Our mission is to improve lives by providing cutting-edge spine surgery solutions.
For more detailed information about our products and ongoing projects, please visit our website at www.alphatecspine.com.
Latest News:
- --- Source: Alphatec Holdings, Inc.
- ---
- ---
- Source: Spineology Inc.
- ---
- ---
Alphatec Holdings, Inc. (ATEC) reported a 68% revenue growth for 2021, with total revenue reaching $243.2 million and Q4 revenue at $74 million. Organic growth in the U.S. was 50%, with a 3-year CAGR of 36%. The GAAP gross margin stood at 64.9%, while operating expenses totaled $285.8 million. ATEC expects 2022 revenue to approximate $305 million, marking a 25% increase. EOS imaging-related revenue contributed $12.8 million. The company trained over 400 surgeons in 2021, enhancing its market presence.
Alphatec Holdings, Inc. (NASDAQ: ATEC) has announced its participation in three upcoming investor conferences. Pat Miles, CEO, and Todd Koning, CFO, will present at the following events:
- The 11th Annual SVB Leerink Global Healthcare Conference: February 17, 2022, at 4:20 pm ET
- The 42nd Annual Cowen Healthcare Conference: March 7, 2022, at 2:50 pm ET
- The 17th Annual Canaccord Genuity Musculoskeletal Conference: March 22, 2022, at 1:00 pm CT
Webcasts will be available on the company's Investor Relations Section.
Alphatec Holdings, Inc. (NASDAQ: ATEC) will announce its fourth quarter and full year 2021 financial results on March 1, 2022, after market close. A live webcast is scheduled for 1:30 p.m. PT / 4:30 p.m. ET. Investors can access the webcast through the Investor Relations Section of ATEC’s website. A replay will be available for twelve months post-event.
Alphatec Holdings, Inc. (NASDAQ: ATEC) announced impressive preliminary revenue results for Q4 and full-year 2021, reflecting a 41-42% U.S. organic revenue growth in Q4 and an annual growth of 50-51%. The total revenue for 2021 is expected between
Alphatec Holdings, Inc. (Nasdaq: ATEC) will present at the 24th Annual Virtual Needham Growth Conference on January 14, 2022, at 1:15 PM ET. The presentation will be made by Pat Miles, Chairman and CEO, and Todd Koning, CFO. A live webcast will be available on the Company’s website, with a replay accessible for 90 days thereafter. ATEC focuses on innovative spine surgery solutions through its subsidiaries, seeking to revolutionize the approach to spine surgery.
Alphatec Holdings, Inc. (Nasdaq: ATEC) reported a significant total revenue growth of 53% for Q3 2021, with organic growth at 29%. The company's total revenue reached $62.9 million, and EOS imaging contributed over $11 million. Operating expenses were $74.7 million leading to a GAAP operating loss of $35.1 million. Looking ahead, ATEC anticipates total revenue for 2021 to be around $235 million, marking approximately 62% growth year-over-year. The adoption of the PTP Technique and enhanced product offerings are driving these results.
Alphatec Holdings, Inc. (Nasdaq: ATEC) announced today its participation in several upcoming investor conferences. Pat Miles, Chairman and CEO, and Todd Koning, CFO, will represent the company at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021, the Stifel Healthcare Conference on November 16, 2021, and the Piper Sandler Conference from November 22 to December 2, 2021. They will also partake in the Stifel Medtech Madness Annual West Coast Bus Tour on December 13, 2021. Webcast replays will be available for 90 days post-conference.
Alphatec Holdings, Inc. (NASDAQ: ATEC) announced it will release its third quarter 2021 financial results on November 4, 2021, after market close. A live webcast will follow at 1:30 p.m. PT / 4:30 p.m. ET. Interested participants can access the webcast via ATEC's Investor Relations website. The results and insights from the call will be available for replay until November 11, 2021.
Alphatec Holdings (NASDAQ: ATEC) has launched the InVictus OsseoScrew Expandable Spinal Fixation System, a state-of-the-art solution designed to enhance spinal fixation in patients with compromised bone quality. This system achieves a 29% increase in pull-out strength compared to conventional screws. Clinical studies indicate that it provides comparable fusion and stability outcomes while mitigating risks associated with cement leakage. The InVictus platform aims to address unmet clinical needs in spine surgery, ensuring safer and more effective patient care.
Alphatec Holdings, Inc. (NASDAQ: ATEC) provided an update on its business amidst the COVID-19 pandemic, which has affected surgical volumes in the spine sector during Q3 2021. Despite lower than expected overall procedure volumes, ATEC anticipates over 25% year-over-year spine revenue growth for the quarter, although revenue will decline sequentially from Q2. The company continues to integrate EOS imaging technology and remains focused on advancing spine surgery innovation. ATEC plans to showcase its solutions at the upcoming NASS 2021 meeting.
FAQ
What is the current stock price of Alphatec Holdings (ATEC)?
What is the market cap of Alphatec Holdings (ATEC)?
What does Alphatec Holdings, Inc. specialize in?
What are some of the key technologies developed by Alphatec Spine?
How does Alphatec Holdings, Inc. improve spine surgery procedures?
What is the mission of Alphatec Holdings, Inc.?
How does Alphatec Holdings, Inc. drive growth?
Where can I find more information about Alphatec Holdings, Inc.?
What recent achievements has Alphatec Holdings, Inc. made?
What are the main products of Alphatec Holdings, Inc.?
How does Alphatec Holdings, Inc. ensure superior patient outcomes?
Is Alphatec Holdings, Inc. involved in any partnerships?
